Page 5 - Les meilleurs doctors traitant la maladie suivante : Cancer du sein - TOP -171 des médecins

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Médecin-chef du centre d'oncologie du centre médical Assuta – expert de premier plan dans le traitement du cancer du sein.

• Spécialisé en oncologie avec un accent sur le cancer du sein
• Occupe un poste de direction dans un centre médical de renommée
• Dédié aux approches de traitement avancées et personnalisées

Le Dr Kaduri se spécialise dans la recherche sur le cancer du sein lié au gène BRCA, avec des études publiées sur l'Oncotype Dx chez les porteuses de BRCA1/2. Elle travaille au centre médical Hadassah.

• Mener des recherches révolutionnaires à l'hôpital The Royal Marsden
• Publier sur les mutations TP53 chez les patients d'origine arabe
• Être lauréate du prix de la Cancer Genetics Research Foundation
• Être membre de la Société israélienne d'oncologie clinique

Le Dr Joseba Rebollo Liceaga apporte plus de 35 ans d'expertise ciblée en oncologie aux soins du cancer du sein chez Quironsalud Torrevieja.

• Chef de services d'oncologie dans plusieurs hôpitaux espagnols de premier plan
• Spécialisé en oncologie médicale à la Clínica Universidad de Navarra
• Recherches publiées sur des traitements innovants tels que l'électrochimiothérapie
• Enseigner aux futurs oncologues en tant qu'ancien médecin associé universitaire

Le Dr Beatrice Uziely dirige le département d'oncologie du centre médical Hadassah et se spécialise dans le cancer du sein depuis plus de 30 ans.

• Chef du département d'oncologie depuis 2001
• Auteur de 59 publications sur la recherche sur le cancer
• Lauréate de 11 subventions pour des études sur le cancer
• Membre de sociétés d'oncologie américaines et européennes

Spécialisé dans le traitement du cancer du sein avec l'expertise de l'Université Hacettepe – l'un des meilleurs centres d'oncologie de Turquie.

• Spécialiste en oncologie médicale avec expérience à l'hôpital d'oncologie de la faculté de médecine de l'Université Hacettepe
• Membre titulaire de l'ESMO (European Society for Medical Oncology)
• Formé à la faculté de médecine de l'Université d'Ankara
• Traiter également les cancers gastro-intestinaux, les lymphomes et les sarcomes

Spécialisé en radiothérapie pour le cancer du sein au centre médical Assuta, se concentrant sur la planification précise du traitement.

• Radiothérapeute expert dans le ciblage efficace des sites tumoraux
• Travaille au centre médical Assuta, reconnu pour ses soins oncologiques de pointe
• Dédié à l'élaboration de plans de traitement personnalisés pour chaque patient

322 publications évaluées par des pairs – Le Dr Kuemmel dirige l'unité multidisciplinaire du sein des Kliniken Essen-Mitte en Allemagne.

• Directeur clinique de l'un des meilleurs centres de cancérologie du sein en Allemagne
• Membre du conseil d'administration de l'Arbeitsgemeinschaft Gynäkologische Onkologie
• Membre de la faculté de l'ESMO avec 1 032 conférences invitées dans le monde entier
• Se spécialiser dans les programmes de traitement holistique du cancer du sein

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

En tant qu'éminent spécialiste de la reconstruction mammaire en Israël, le Dr Eldor est directeur du département de chirurgie plastique et reconstructrice du centre médical Rambam.

• Se spécialiser exclusivement dans la chirurgie reconstructrice du sein et du visage, y compris la microchirurgie
• Étudier les causes génétiques du cancer du sein et les techniques de réinnervation mammaire après traitement
• Détenir un diplôme de l'American Medical School du Technion et avoir été formé aux États-Unis à l'Université Baylor
• Être membre de la Société israélienne de chirurgie plastique et esthétique et de l'Association israélienne de lutte contre le cancer

Le Dr Drumea est une spécialiste qui se consacre exclusivement à l'utilisation de la radiothérapie pour le traitement du cancer. Elle exerce au célèbre centre médical Rambam.

• Traiter le cancer du sein en adaptant la radiothérapie au cas de chaque patient.
• Posséder une double certification en oncologie et en radiothérapie.
• Permettre une approche thérapeutique intégrée grâce à cette spécialisation.
• Travailler au sein d'un centre médical pluridisciplinaire de haut niveau.

Le Dr Leng Yin est spécialisé dans le traitement du cancer du sein ainsi que dans l'oncologie du foie, de la vésicule biliaire et du pancréas à l'hôpital anticancéreux Fuda.

• Oncologue à l'hôpital international Bumrungrad et à l'hôpital Royal Siriraj en Thaïlande
• Membre de l'Association chinoise contre le cancer
• Expertise dans de multiples traitements d'oncologie gastro-intestinale et mammaire